Processing your payment...
Please do not close your browser.

Montelukast Sodium Market - Growth, Trends And Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Morepen Laboratories, Mylan, TAPI, MSN Laboratories

06 Jan, 2020 | 120 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

The global montelukast sodium Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 13.4% during the review period (2022 to 2027)



Montelukast Sodium Market Overview



Montelukast sodium is a leukotriene inhibitory agent that is used for several indications that includes asthma, exercise induced bronchospasm, allergic rhinitis, primary dysmenorrhea and urticaria. It is frequently used as a complementary therapy in adults along with inhaled corticosteroids, if the effect produced by corticoids are not optimum. Key factors driving the progress of this market are the rise in respiratory diseases coupled with the growing geriatric population. But, side effects related to montelukast sodium such as stomach pain, heartburn, upset stomach, nausea, and diarrhea will surely impede the market growth. Also, the increasing R&D investments to develop novel drugs and the advancements in technology will create lucrative opportunities for key market players.Asthma is considered to be one of the world's main common diseases affecting the population and is also a life-threatening condition affecting patients' regular breathing. It is a persistent condition that stretches and narrows the air passages of the lungs, causing constant assaults of breathlessness, bronchospasm, and reversible obstruction of airflow. Moreover, there is a large rise in the number of cigarettes, which contributes to asthma symptoms.



Industry News



Morepen gets US FDA clearance for Montelukast Sodium



The United States Food and Drug Administration (US FDA) has cleared Montelukast Sodium, a bulk drug / API manufactured by Morepen Laboratories, for sale in the US market. This gives Morepen an entry into the Rs 2000 crore (Approx $ 300 million) US market for Montelukast.



In December 2021, Drug firm Morepen Laboratories on has received approval from the United States health regulator to market its generic anti-allergy drug (Fexofenadine Hydrochloride) in the American market.



What are the major Applications, Types and Regions for Montelukast Sodium Market?



Montelukast Sodium Market is segmented based on the type, applications, companies and regions.



By Type, it is segmented int




  • Montelukast Sodium Crystalline

  • Montelukast Sodium Amorphous



By Applications it is segmented into




  • Tablets

  • Chewable Tablet

  • Oral Solution



Montelukast Sodium Market Regional Analysis



The report offers in-depth assessment of the growth and other aspects of the Montelukast Sodium Market in important regions, including the 



North America






    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East & Africa

    • Latin America





North America is expected to dominate the overall market, due to factors, such as the presence of key players, high prevalence of asthma and other respiratory diseases, established healthcare infrastructure, which are some of the key factors accountable for its large share in the market. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase the market growth.



In this region, the United States has the maximum share due to supportive healthcare policies, a high number of patients, and a developed healthcare market. According to the Centers for Disease Control, around 8.1% of the population of the United States had asthma. As per the statistics, the increasing patient pool and increasing disposable revenue in this country boost the market growth of the region.



What is our Montelukast Sodium Market report scope?























































 



Report Attributes



 



 



Report Details



 



Forecast Period 2022 to 2027 CAGR



 



CAGR of 13.4% during the review period (2022 to 2027).



 



By Type




  • Montelukast Sodium Crystalline

  • Montelukast Sodium Amorphous



 



By Application




  • Tablets

  • Chewable Tablet

  • Oral Solution



 



 



 



By Companies



 



Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, Hetero Labs, Unimark Remedies, Jubilant Cadista, Aamorb Pharmaceuticals, Sudarshan Groups, Ortin Laboratories, Vamsi Labs, Adley Group, Medopharm, Hengyuan Pharmaceutical, Arromax Pharmaceutical Technology, Lihe Wuhan New Chemical Materials, Shanghai Huachu Chemical and others.



 



 



Regions Covered



 




  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World



 



 



 



 



 



 



 



 



Countries Covered




  • US

  • Canada

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Latin America



 



Base Year



 



 



2022



 



Historical Year



 



 



2017 to 2021



 



Forecast Year



 



 



2022 to 2027


Number of Pages 120

 



Customization Available



 



 



Yes, the report can be customized as per your needs




Key Takeaways from this Montelukast Sodium Report




  • Evaluate Montelukast Sodium market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.

  • Understand the different dynamics influencing the market - key driving factors, challenges and hidden opportunities.

  • Get in-depth insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

  • Analyze the sales and distribution channels across key geographies to improve top-line revenues.

  • Understand the industry supply chain with a deep dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

  • Get a quick outlook on the Montelukast Sodium market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.

  • Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.



All our reports are customizable to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.



Frequently Asked Questions



What is the study period of this market?



 The Montelukast Sodium Market is studied from 2022 - 2027.



What is the growth rate of Montelukast Sodium Market?



The Montelukast Sodium Market is growing at a CAGR of 13.4% over the next 5 years.



What region does this Montelukast Sodium Market report covers?



North America (the United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, and Italy) Asia-Pacific (China, Japan, Korea, India, and Southeast Asia) South America (Brazil, Argentina, Colombia, etc.) The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)



All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.


  1. INTRODUCTION

    1. MARKET DEFINATION

    2. MARKET DYNAMICS

    3. MARKET SEGMENTATION

    4. REPORT TIMLINES

    5. KEY STAKEHOLDERS



  2. RESEARCH METHODOLOGY

    1. DATA MINING

      1. SECONDARY RESEARCH

      2. PRIMARY RESEARCH

      3. SUBJECT MATTER EXPERT ADVICE



    2. QUALITY CHECK

    3. FINAL REVIEW

      1. DATA TRIANGULATION

      2. BOTTOM-UP APPROACH

      3. TOP-DOWN APPROACH

      4. RESEARCH FLOW





  3. EXECUTIVE SUMMARY

    1. INTRODUCTION

    2. GLOBAL MONTELUKAST SODIUM MARKET BY TYPES

    3. GLOBAL MONTELUKAST SODIUM MARKET BY APPLICATIONS



  4. MARKET DYNAMICS

    1. DRIVERS

      1. INCREASING DEMAND FOR MONTELUKAST SODIUM



    2. RESTRAINTS

      1. STRINGENT ENVIRONMENTAL REGUALTIONS

      2. HIGH COST ON MATERIALS



    3. OPPORTUNITIES

      1. MONTELUKAST SODIUM GROWTH

      2. APPLICATION OF MONTELUKAST SODIUM



    4. IMPACT OF COVID 19



  5. GLOBAL MONTELUKAST SODIUM MARKET, BY TYPES

    1. Introduction

    2. Montelukast Sodium Crystalline

    3. Montelukast Sodium Amorphous

    4. Other            



  6. GLOBAL MONTELUKAST SODIUM MARKET, BY APPLICATION

    1. Introduction

    2. Tablets

    3. Chewable Tablet

    4. Oral Solution

    5. Others   



  7. GLOBAL MONTELUKAST SODIUM MARKET, BY REGION

    1. NORTH AMERICA

      1. US

      2. CANADA

      3. MEXICO



    2. EUROPE

      1. GERMANY

      2. FRANCE

      3. UK

      4. ITALY

      5. RUSSIA

      6. REST OF EUROPE



    3. APAC

      1. CHINA

      2. SOUTH KOREA

      3. JAPAN

      4. INDIA

      5. AUSTRALIA

      6. ASEAN

      7. REST OF APAC



    4. MIDDLE EAST & AFRICA

      1. SAUDI ARABIA

      2. UAE

      3. SOUTH AFRICA

      4. TURKEY

      5. REST OF MEA



    5. SOUTH AMERICA

      1. BRAZIL

      2. REST OF MEA

      3. ARGENTINA

      4. REST OF SOUTH AMERICA





  8. COMPETITIVE LANDSCAPE

    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,

    2. AND AGREEMENTS

      1. KEY DEVELOPMENT



    3. MARKET SHARE (%) **/RANKING ANALYSIS

    4. STRATEGIES ADOPTED BY LEADING PLAYERS



  9. COMPANY PROFILES

    1. BUSINESS OVERVIEW

    2. COMPANY SNAPSHOT

    3. PRODUCT BENCHMARKING

    4. STRATEGIC INITIATIVES

      1. Morepen Laboratories,

      2. Mylan,

      3. TAPI,

      4. MSN Laboratories,

      5. Ultratech India,

      6. Aurobindo Pharma,

      7. Hetero Labs,

      8. Unimark Remedies,

      9. Jubilant Cadista,

      10. Aamorb Pharmaceuticals,

      11. Sudarshan Groups,

      12. Ortin Laboratories,

      13. Vamsi Labs,

      14. Adley Group,

      15. Medopharm,

      16. Hengyuan Pharmaceutical,

      17. Arromax Pharmaceutical Technology,

      18. Lihe Wuhan New Chemical Materials,

      19. Shanghai Huachu Chemical and others.





SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Merck
  • IBM
  • Dow
  • Henkel
  • AirBus
  • Cummins
  • Intel
  • Sony
  • 3M
  • 3M
  • 9